Medical device company Arrotek to create 100 jobs in Sligo

Sligo medical device company Arrotek said it was planning to create 100 jobs after getting the go-ahead for a multimillion euro expansion to its headquarters.

The company is planning a 1,858sq m (20,000sq ft) extension to its premises at Finisklin Business Park in Sligo, where it already has a purpose-built 4,645sq m (50,000sq ft) facility with state-of-the-art manufacturing cleanrooms, laboratory and engineering offices. The new extension will add a mixture of office and manufacturing space.

Recruitment for the new roles will begin immediately, with the company hiring across all departments including design engineers and project managers, quality, production, finance, customer service and administration.

"It is fantastic to see the growth of the business over the last 17 years, and it is extremely positive that a home-grown Sligo company has managed to grow into international markets and create high-quality jobs for Sligo and the northwest of Ireland, " said Arrotek co-founder Ger O'Carroll. "This is testament to the high-quality workforce that we currently have and will be recruiting into the future."

Takeda stem cell facility puts Irish pharma at cutting edge of modern medicine

---

Takeda opens Ireland’s first stem cell manufacturing plant

---

Open Orphan subsidiary signs deal with global pharma company

---

Galway medtech Versono Medical raises €6.7m in funding

---

Arrotek was founded in 2005 by Mark Pugh and Mr O'Carroll as an engineering service provider focused on designing medical devices for other companies. It has seen steady growth ever since, and opened its headquarters in Finisklin in 2019.

In the past two years, the company has doubled its workforce and expanding its manufacturing operations.

“Since Ger and I set up the business back in 2005, we have focused on investing in the latest cutting-edge technologies to allow us to offer a service that is world-class,” said Mr Pugh.

“This current investment will allow us to further enhance our service offerings to all our current customers both start ups and multinationals, as well as grow into emerging markets.”